Author

S. Chaurasiya

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Kumar· 1 shared A. M. Strom· 1 shared A. Poral· 1 shared C. M. Botero· 1 shared C.-Y. Lin· 1 shared D. K. Georgiou· 1 shared D. R. Lenka· 1 shared E. Chang· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Kumar

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Specific interactions with phospho-Ubls and allosteric conformational changes regulate the E3 ligase activity of Parkin

D. R. Lenka, S. Chaurasiya, A. Kumar

This study determines the crystal structure of Parkin bound with phospho-NEDD8, revealing how phospho-Ubls and conformational changes regulate Parkin's E3 ligase activity.

bioRxiv · Nov 21, 2023 · PreprintBiochemistry

Anaplerotic nutrient stress drives synergy of angiogenesis inhibitors with therapeutics targeting tumor metabolism

S. Khadka, Y.-H. Lin, J. J. Ackroyd, Y.-A. Chen, Y. Sheng, W. Qian, S. Guo, Y. Chen, E. I. Behr, Y. Barekatain, M. N. Uddin, K. Arthur, V. C. Yan, E. Chang, A. Poral, , F. L. Muller

This study shows that angiogenesis inhibitors enhance the effectiveness of metabolic therapies in gliomas by inducing anaplerotic nutrient stress.

bioRxiv · May 7, 2023 · PreprintCancer Biology

Estrogen receptor β exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity

A. M. Strom, S. Chaurasiya, S. M. Widmann, C. M. Botero, C.-Y. Lin, J.-A. Gustafsson

This study shows that estrogen receptor β suppresses prostate cancer by reducing androgen receptor activity through gene expression and metabolic changes.

bioRxiv · Nov 20, 2019Cancer Biology